[1]. James D. Watson Molecular Biology of the Gene; 7th edition.; 2004;
[2]. Schlake, T.; Thess, A.; Fotin-Mleczek, M.; Kallen, K.-J. Developing MRNA-Vaccine Technologies. RNA Biol 2012, 9, 1319–1330, doi:10.4161/rna.22269.
[3]. Karikó, K.; Weissman, D. Naturally Occurring Nucleoside Modifications Suppress the Immunostimulatory Activity of RNA: Implication for Therapeutic RNA Development. Curr Opin Drug Discov Devel 2007, 10, 523–532.
[4]. Zamani, P.; Mashreghi, M.; Rezazade Bazaz, M.; Zargari, S.; Alizadeh, F.; Dorrigiv, M.; Abdoli, A.; Aminianfar, H.; Hatamipour, M.; Zarqi, J.; et al. Characterization of Stability, Safety and Immunogenicity of the MRNA Lipid Nanoparticle Vaccine Iribovax® against COVID-19 in Nonhuman Primates. Journal of Controlled Release 2023, 360, 316–334, doi: 10.1016/j.jconrel.2023.06.025.
[5]. Pilkington, E.H.; Suys, E.J.A.; Trevaskis, N.L.; Wheatley, A.K.; Zukancic, D.; Algarni, A.; Al-Wassiti, H.; Davis, T.P.; Pouton, C.W.; Kent, S.J.; et al. From Influenza to COVID-19: Lipid Nanoparticle MRNA Vaccines at the Frontiers of Infectious Diseases. Acta Biomater 2021, 131, 16–40, doi: 10.1016/j.actbio.2021.06.023.
[6]. Dolgin, E. The Tangled History of MRNA Vaccines. Nature 2021, 597, 318–324, doi:10.1038/d41586-021-02483-w.
[7]. Casadevall, A. The MRNA Vaccine Revolution Is the Dividend from Decades of Basic Science Research. Journal of Clinical Investigation 2021, doi:10.1172/JCI153721.
[8]. Press Release. NobelPrize.Org. Nobel Prize Outreach AB 2023. Wed. 25 Oct 2023. <https://Www.Nobelprize.Org/Prizes/Medicine/2023/Press-Release/>.
[9]. Karikó, K. Modified Uridines Are the Key to a Successful Message. Nat Rev Immunol 2021, 21, 619–619, doi:10.1038/s41577-021-00608-w.
[10]. Advanced Information. NobelPrize.Org. Nobel Prize Outreach AB 2023. Wed. 25 Oct 2023. <https://Www.Nobelprize.Org/Prizes/Medicine/2023/Advanced-Information/>.
[11]. Karikó, K.; Buckstein, M.; Ni, H.; Weissman, D. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity 2005, 23, 165–175, doi:10.1016/j.immuni.2005.06.008.
[12]. Schlake, T.; Thess, A.; Fotin-Mleczek, M.; Kallen, K.-J. Developing MRNA-Vaccine Technologies. RNA Biol 2012, 9, 1319–1330, doi:10.4161/rna.22269.
[13]. Edouard Mathieu and Hannah Ritchie and Lucas Rodés-Guirao and Cameron Appel and Charlie Giattino and Joe Hasell and Bobbie Macdonald and Saloni Dattani and Diana Beltekian and Esteban Ortiz-Ospina and Max Roser Coronavirus Pandemic (COVID-19). Our World in Data 2020.
[14]. Pardi, N.; Hogan, M.J.; Porter, F.W.; Weissman, D. MRNA Vaccines — a New Era in Vaccinology. Nat Rev Drug Discov 2018, 17, 261–279, doi:10.1038/nrd.2017.243.
[15]. Rosa, S.S.; Prazeres, D.M.F.; Azevedo, A.M.; Marques, M.P.C. MRNA Vaccines Manufacturing: Challenges and Bottlenecks. Vaccine 2021, 39, 2190–2200, doi: 10.1016/j.vaccine.2021.03.038.
[16]. Wadhwa, A.; Aljabbari, A.; Lokras, A.; Foged, C.; Thakur, A. Opportunities and Challenges in the Delivery of MRNA-Based Vaccines. Pharmaceutics 2020, 12, 102, doi:10.3390/pharmaceutics12020102.
[17]. Lin, L.; Pei, Y.; Li, Z.; Luo, D. Progress and Challenges of MRNA Vaccines. Interdisciplinary Medicine 2023, 1, doi:10.1002/INMD.20220008.
[18]. Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Pérez Marc, G.; Moreira, E.D.; Zerbini, C.; et al. Safety and Efficacy of the BNT162b2 MRNA Covid-19 Vaccine. New England Journal of Medicine 2020, 383, 2603–2615, doi:10.1056/NEJMoa2034577.
[19]. Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; et al. Efficacy and Safety of the MRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine 2021, 384, 403–416, doi:10.1056/NEJMoa2035389.
[20]. Bayani, F.; Hashkavaei, N.S.; Arjmand, S.; Rezaei, S.; Uskoković, V.; Alijanianzadeh, M.; Uversky, V.N.; Ranaei Siadat, S.O.; Mozaffari-Jovin, S.; Sefidbakht, Y. An Overview of the Vaccine Platforms to Combat COVID-19 with a Focus on the Subunit Vaccines. Prog Biophys Mol Biol 2023, 178, 32–49, doi: 10.1016/j.pbiomolbio.2023.02.004.